High-Dose Cyclophosphamide is Effective Therapy for Pediatric Severe Aplastic Anemia

OBJECTIVE: Use of high-dose cyclophosphamide without hematopoietic stem cell transplant (HSCT) to treat severe aplastic anemia (SAA) has been controversial due to concern for increased infectious toxicity as compared to anti thymocyte globulin (ATG) and cyclosporine (CSA). As children often tolerate...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Pediatr Hematol Oncol
Egile Nagusiak: Gamper, Christopher J., Takemoto, Clifford M., Chen, Allen R., Symons, Heather J., Loeb, David M., Casella, James F., Dezern, Amy E., King, Karen E., McGonigle, Andrea M., Jones, Richard J., Brodsky, Robert A.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2016
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5074865/
https://ncbi.nlm.nih.gov/pubmed/27467367
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MPH.0000000000000647
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak